Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 237,883,528 papers from all fields of science
Search
Sign In
Create Free Account
European Organization for Research and Treatment of Cancer
Known as:
EORTC
A group with aims to conduct, develop, coordinate, and stimulate laboratory and clinical research in Europe to improve the management of cancer and…
Expand
National Institutes of Health
Create Alert
Alert
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
2015
2015
Comparing a Single Immediate Instillation of Chemotherapy After Transurethral Resection with Transurethral Resection Alone in Patients with Stage pTa – pT 1 Urothelial Carcinoma of the Bladder…
R. Sylvester
,
W. Oosterlinck
,
+13 authors
M. Babjuk
2015
Corpus ID: 207863129
a EORTC Headquarters, Department of Biostatistics, Brussels, Belgium; b Ghent University Hospital, Department of Urology, Ghent…
Expand
2014
2014
EORTC Quality of Life Questionnaire
N. Aaronson
,
A. Cull
,
S. Kaasa
,
M. Sprangers
2014
Corpus ID: 86556876
2008
2008
Interferon-α (IFN), interleukin-2 (IL2) and 5-fluorouracil (5FU) vs IFN alone in patients with metastatic renal cell carcinoma (mRCC): Results of the randomised MRC/EORTC RE04 trial
M. Gore
2008
Corpus ID: 78475479
5039 Background: Until the recent introduction of the targeted agents, standard of care for patients with mRCC in Europe has…
Expand
2007
2007
Final Results of the EORTC Intergroup Randomized Phase 3 Study 40983 Evaluating the Benefit of Perioperative FOLFOX4 Chemotherapy for Patients with Potentially Resectable Colorectal Cancer Liver…
C. Helwick
,
N. Nordlinger
2007
Corpus ID: 71134746
2003
2003
Lebensqualität laryngektomierter Patienten nach chirurgischer Stimmrehabilitation
M. Tisch
,
K. Lorenz
,
E. Störrle
,
H. Maier
HNO (Berlin. Print)
2003
Corpus ID: 37026180
ZusammenfassungHintergrund. 52 Patienten mit chirurgischer Stimmrehabilitation durch Provox®-Prothese I nach Laryngektomie wegen…
Expand
2002
2002
First-line treatment of ovarian cancer FIGO stages IIb-IV with paclitaxel/epirubicin/carboplatin (TEC) vs paclitaxel/carboplatin (TC). Interim results of an NSGO-EORTC-NCIC CTG Gynaecological Cancer…
G. Kristensen
,
I. Vergote
,
+8 authors
E. Eisenhauer
2002
Corpus ID: 78178697
Review
1997
Review
1997
The current EORTC Melanoma Cooperative Group adjuvant trial programme on malignant melanoma: prognosis versus efficacy, toxicity and costs
A. Eggermont
Melanoma research
1997
Corpus ID: 13336624
Various adjuvant therapy trials in high risk melanoma are at present ongoing in the world. Interferon-α (IFN-α) and ganglio-side…
Expand
1996
1996
Another look at induction chemotherapy for organ preservation in patients with head and neck cancer.
A. Forastiere
Journal of the National Cancer Institute
1996
Corpus ID: 29329928
chemotherapy followed by radiotherapy as its new standard for comparison of future organ-sparing strategies. The EORTC trial…
Expand
Review
1988
Review
1988
Combination of cisplatin, vindesine, and dacarbazine in advanced malignant melanoma. A phase II study of the eortc malignant melanoma cooperative group
MD C. F. VERSCHRAEGEN
,
MD U. R. KLEEBERG
,
+6 authors
MS S. SUCIU
Cancer
1988
Corpus ID: 36747016
A Phase II study combining cisplatin, vindesine, and dacarbazine was performed on patients with disseminated malignant melanoma…
Expand
Review
1985
Review
1985
Review and evolution of clinical results in the EORTC Heavy-Particle Therapy Group.
A. Wambersie
,
J. Battermann
Strahlentherapie
1985
Corpus ID: 32398837
Part of the clinical results from the "EORTC Heavy-Particle Therapy Group" are reviewed (September 1984). Fast neutrons can bring…
Expand